Montral -- Researchers at Universit de Montral and the Institut de recherches cliniques de Montral (IRCM) have successfully identified a defective immune cell population that determines susceptibility to candidiasis, a common and often debilitating infection in individuals infected with the human immunodeficiency virus (HIV). These findings, revealed using a model of candidiasis in transgenic mice expressing HIV developed by the same research group, represents a milestone in developing a treatment for the infection and, eventually, preventing it. They are described in an article of the July 1st issue of The Journal of Immunology.
Oral and esophageal Candida albicans infections, which often affect individuals infected with HIV, may limit food consumption and lead to weight loss, threatening patients' general health and well-being. Of added concern, treatment of candidiasis in these patients is often complicated by strains of Candida albicans resistant to conventional antifungal therapies. The research project was carried out jointly by Dr. Louis de Repentigny, Director of the Medical Mycology Laboratory and Professor in the Department of Microbiology and
Immunology at the Faculty of Medicine of Universit de Montral, and at CHU Sainte-Justine, and Dr. Paul Jolicoeur, Director of the
Molecular Biology Research Unit at the Institut de recherches cliniques de Montral (IRCM), researcher in the Department of Microbiology and Immunology at the Faculty of Medicine of Universit de Montral, associate member of the McGill University Faculty of Medicine and holder of the Canada Research Chair on Infectious and Parasitic Diseases and Dr Zaher Hanna, Associate Director in the same Unit, researcher in the Department of Medicine at the Faculty of Medicine of Universit de Montral, associate member of the McGill University Division of Experimental Medicine.
Drs de Repentigny, Jolicur and Hanna have for the first time succeeded in demonstrating that defective CD4+
'"/>
Contact: Sophie Langlois
sophie.langlois@umontreal.ca
514-343-7704
University of Montreal
21-Jun-2006
Page: 1 2 Related medicine news :1.
Montreal researchers make a major strategic breakthrough in controling the AIDS virus2.
As Montreal Conference considers deforestation issues, ESA presents space solution3.
ESA participating in UNs Montreal summit working for a better atmosphere4.
Stanford researchers find culprit in aging muscles that heal poorly5.
UCLA researchers awarded $9M contract for study identifiying antibiotic treatment for MRSA6.
Penn researchers discover novel pathway for increasing good cholesterol7.
Theory of facial aging gets a facelift from UT Southwestern researchers8.
UIC researchers to develop new drugs to fight bioterrorism9.
UQ researchers discover some of the oldest forms of life10.
U of M researchers discover new method to combat HIV11.
U of M researchers assess effectiveness of computerized physician order entry system